Tranexamic acid in hip fracture surgery: A systematic review and meta-analysis.

Bashar Haj-YounesBrahman Shankar SivakumarMichael WangVincent V G AnPeter LorentzosSam Adie

Published in: Journal of orthopaedic surgery (Hong Kong) (2020)

There is evidence that TXA reduces the proportion of patients requiring blood transfusions when undergoing hip fracture surgery. However, the small sample size and low event rates for adverse effects preclude any definitive conclusions from being established regarding adverse effects. Future trials should be powered to further assess potential complications and determine the ideal dosage and regime.

Keyphrases

hip fracture
minimally invasive
coronary artery bypass
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
surgical site infection
prognostic factors
patient reported outcomes
risk assessment
radiation therapy